Bavarian Nordic Secures Vaccine Order From European Country After Confirmed Monkeypox Cases
COPENHAGEN, Denmark, May 19, 2022 – Bavarian Nordic A/S (OMX:
BAVA) announced today that the Company has secured a contract with an
undisclosed European country to supply its IMVANEX® smallpox vaccine in
response to new cases of monkeypox evolving during May 2022.
More info >> |